top of page
Asset 2.png

The institution was created in 1969 with the name Digital Research Center (CID), later Central Digital Research Institute (ICID), in order to develop the first Cuban computer, which ended in 1970. In the mid-1980s, the ICID refocuses its principal activity on the design, development, production and sales of medical devices, including the after-sales service activities for them. In 1995, COMBIOMED was created as a commercial brand and marketing company of ICID. In 2012, ICID and COMBIOMED joined the BioCubaFarma group, representing all companies in Cuba's biotechnology, pharmaceutical, medical equipment, and devices industries.


In December 2018, ICID and COMBIOMED merged and the company COMBIOMED DIGITAL MEDICAL TECHNOLOGY, a closed-cycle company:

  1. Conceptualisation

  2. Research and Development

  3. Validation

  4. Medical Registry

  5. Manufacturing

  6. Commercialisation and Technical Assistance

COMBIOMED operation covers all stages, from the product's conception to the technical assistance during the exploitation of the product. The main business lines are linked to:

  • Cardiovascular diagnosis and rehabilitation.

  • Patient monitoring and life support.

  • Electrostimulation.

  • Diagnosis of chronic respiratory diseases.

  • Solutions for primary health care.

The quality system of the company is certified by the National Standardisation Office of Cuba (ONN) and the Spanish Association for Standardisation (AENOR) according to the standards ISO 9001:
2015 and ISO 13485: 2016

bottom of page